Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019

Clinical Laboratory
|September 9, 2020
PubMed

Insights

Routine blood tests can help diagnose coronavirus disease 2019 (COVID-19) when real-time reverse transcription polymerase chain reaction assay (RT-PCR) is unavailable. Biomarkers like ferritin, lymphocytes, and eosinophils accurately differentiate between COVID-19 and non-COVID-19 patients.

Area of Science:

  • Clinical diagnostics
  • Biomarker discovery
  • Infectious disease management

Background:

  • Real-time reverse transcription polymerase chain reaction assay (RT-PCR) is the standard for COVID-19 diagnosis but faces accessibility and speed limitations.
  • Evaluating routine blood tests offers a potential alternative for timely COVID-19 diagnosis.

Purpose of the Study:

  • To assess the diagnostic accuracy of routine blood tests for differentiating COVID-19 patients from non-COVID-19 patients.
  • To establish reliable blood biomarker cutoff values for suspected COVID-19 cases.

Main Methods:

  • Retrospective review of clinical data, laboratory findings, and chest X-rays from adult patients with suspected COVID-19.
  • Patients were categorized into COVID-19 positive and negative groups based on RT-PCR results.
  • Receiver operating characteristic (ROC) curve analysis was employed to determine diagnostic accuracy (AUC) and optimal cutoff values, prioritizing 80% specificity.

Main Results:

  • Plasma ferritin demonstrated the highest accuracy (AUC 0.847 in women, 0.804 in men).
  • Established cutoff values for lymphocytes, eosinophils, ferritin, LDH, hsCRP, and D-dimer showed varying sensitivities.
  • 91% of COVID-19 patients met at least one biomarker criterion, while 47% of non-COVID-19 patients met none.

Conclusions:

  • Blood biomarkers including lymphocytes, eosinophils, D-dimer, LDH, hsCRP, and ferritin can effectively differentiate COVID-19 from non-COVID-19 patients.
  • These biomarkers serve as a valuable diagnostic tool for suspected COVID-19 in adult hospital admissions.
Abstract